Sex Hormones and Hepatic Neoplasia

Cancer Research

Volumn 36, Issue , 1976, Pages 2584-2588

  Goldfarb, Stanley ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; CHLORMADINONE ACETATE; CHLORMADINONE ACETATE PLUS MESTRANOL; DIMETHISTERONE; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETYNODIOL DIACETATE; ETYNODIOL DIACETATE PLUS MESTRANOL; MESTRANOL; MESTRANOL PLUS NORETHISTERONE; NORETHISTERONE; NORGESTREL; ORACON; UNCLASSIFIED DRUG;

CARCINOGENESIS; CLINICAL STUDY; CONTRACEPTION; LIVER CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; ORACON;

ADENOMA; ADULT; ANABOLIC STEROIDS; BILE ACIDS AND SALTS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, ORAL, SYNTHETIC; FEMALE; HAMARTOMA; HUMAN; HYPERPLASIA; LIVER; LIVER NEOPLASMS; MALE; MODELS, BIOLOGICAL;

EID: 0017162056     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Ameriks, J. A., Thompson, N. W., Frey, C. F. Appelman, H. D., and Walter, J. F. Hepatic Cell Adenomas, Spontaneous Liver Rupture and Oral Contraceptives. Arch. Surg., 110: 548–557, 1975.
2. Anthony, P. P. Hepatoma Associated with Androgenic Steroids. Lancet. 1: 485–486, 1975.
3. Anthony, P. P., Vogel, C. L., and Barker. L. F. Liver Cell Dysplasia: A Premalignant Condition. J. Clin. Pathol., 26: 217–223, 1973.
4. Antoniades, K., and Brooks. C. E. Hemoperitoneum from Liver Cell Adenoma in a Patient on Oral Contraceptives. Surgery. 77: 137–139. 1975.
5. Bagheri, S. A., and Boyer, J. L. Peliosis Hepatis Associated with Androgenic-Anabolic Steroid Therapy. Ann. Intern. Med., 81: 610–618, 1974.
6. Baum, J. K., Holtz, F., Bookstein, J. J., and Klein, E. W. Possible Association between Benign Hepatomas and Oral Contraceptives. Lancet, 2: 926–929, 1973.
7. Benz, E. J., and Baggenstoss, A. H. Focal Cirrhosis of the Liver, Its Relation to the So-called Hamartoma (Adenoma, Benign Hepatoma). Cancer, 6: 743–755, 1953.
8. Bernstein, M. S., Hunter, R. L., and Yachnin, S. Hepatoma and Peliosis Hepatis Developing In a Patient with Fanconi's Anemia. New Engl. J. Med., 284: 1135–1136, 1971.
9. Bolt, H. M., and Kappus. H. Irreversible Binding of Ethynyl-Estradiol Metabolites to Protein and Nucleic Acids as Catalyzed by Rat Liver Microsomes and Mushroom Tyrosinase. J. Steroid Biochem., 5: 179–184, 1974.
10. Bolt, H. M., Kappus, H., and Kasbohrer, R. Metabolism of 17-a Ethinyl-estradiol by Human Liver Microsomes in Vitro: Aromatic Hydroxylation and Irreversible Protein Binding of Metabolites. J. Clin. Endocrinol. Metab., 39: 1072–1080, 1974.
11. Bolt, H. M., Kappus, H., and Remmer, H. Studies on the Metabolism of Ethynylestradiol in Vitro and in Vivo: The Significance of a-Hydroxylation and the Formation of Polar Products. Xenobiotica, 3: 773–785, 1973.
12. Broguera, M. Hepatoma Associated with Androgenic Steroids. Lancet, 1: 1295, 1975.
13. Carcinogenicity Tests of Oral Contraceptives. A Report by the Committee on the Safety of Medicines. London, Her Magesty's Stationery Office, 1972.
14. Carter, R. Hepatoblastoma in the Adult. Cancer, 223: 191–197, 1969.
15. Christopherson, W. M., Mays, E. T., and Barrows, G. H. Liver Tumors in Woman on Contraceptive Steroids. Obstet. Gynecol., 46: 221-223, 1975.
16. Conney, A. H. Pharmacological Implications of Microsomal Enzyme Induction. Pharmacol. Rev., 19: 317–366, 1967.
17. Contostavlos, D. L. Benign Hepatomas and Oral Contraceptives. Lancet, 2: 1200, 1973.
18. DeLorimier, A. A., Gordon, G. S., Lowe, R. C., and Carbone, J. V. Methyltestosterone, Related Steroids, and Liver Function. Arch. Intern. Med., 116: 289–294, 1965.
19. Edmondson, H. A. Differential Diagnosis of Tumors and Tumor-like Lesions of Liver in Infancy and Childhood. Am. J. Diseases Children, 91: 168–186, 1956.
20. Farrell, G. C., Joshua, D. E., Uren, R. F., Baird, P. J., Perkins, K. W., and Kronenberg, H. Androgen-induced Hepatoma. Lancet, 1: 430–431, 1975.
21. Fotherby, K. Metabolism of Synthetic Steroids by Animals and Man. Acta Endocrinol. Suppl., 185: 119–147, 1974.
22. Gallagher, T. F., Mueller, M. N., and Kappas, A. Estrogen Pharmacology. IV. Studies on the Structural Basis for Estrogen-induced Impairment of Liver Function. Medicine, 45: 471–479, 1966.
23. Guy, J. T., and Auslander, M. O. Androgenic Steroids and Hepatocellular Carcinoma. Lancet, 1: 148, 1973.
24. Harkavy, M., and Javitt, N. B. Effect of Ethynyl Estradiol on Hepatic Excretory Function of the Rat. In: H. A. Salhanick, D. M. Kipnis, and R. L. Vande Welde (eds.) Conference on Metabolic Effects of Gonadal Hormones and Contraceptive Steroids, pp. 11–18. New York: Plenum Press, 1969.
25. Henderson, J. T., Richmond, J., and Sumerling, M. D. Androgenic-Anabolic Steroid Therapy and Hepatocellular Carcinoma. Lancet, 1: 934, 1973.
26. Henson, S. W., Jr., Gray, H. K., and Dockerty, M. B. Benign Tumors of the Liver: I. Adenomas. Surg. Gynecol. Obstet., 103: 23–30, 1956.
27. Heston, E. C. Vlahakis, G., and Desmukes, B. Effects of the Antifertility Drug Enovid in Five Strains of Mice, with Particular Regard to Carcinogenesis. J. Natl. Cancer Inst., 51: 209–224, 1973.
28. Horvath, E., Kovacs, K., and Ross, R. Ultrastructural Findings in a Well-differentiated Hepatoma. Digestion, 7: 74–82, 1972.
29. Horvath, E., Kovacs, K., and Ross, R. C. Benign Hepatoma in a Young Woman on Contraceptive Steroids. Lancet, 1: 357–358, 1974.
30. Ingelfinger, F. J. Gallstones and Estrogens. New Engl. J. Med., 290: 51–52, 1974.
31. Ishak, K. G., and Rabin, L. Benign Tumors of the Liver. Med. Clin. N. Am. 59: 995–1013, 1975.
32. Johnson. F. L., Feagler, J. R., Lerner, K. G., Majerus, P. W., Siegel, M., Hartmann, J. R., and Thomas, E. D. Association of Androgenic-Anabolic Steroid Therapy with Development of Hepatocellular Carcinoma. Lancet. 2: 1273–1276, 1972.
33. Kaplowitz, N., Kok, E., and Javitt, N. B. Postprandial Serum Bile Acid for the Detection of Hepatobiliary Disease. J. Am. Med. Assoc., 225: 292–293, 1973.
34. Kelso, D. R. Benign Hepatomas and Oral Contraceptives. Lancet, 1: 315–316, 1974.
35. Knapp, W. A., and Ruebner, B. H. Hepatomas and Oral Contraceptives. Lancet, 1: 270–271, 1974.
36. Korman, M. G., La Russo, N. F., Hoffman, N. E., and Hoffman, A. F. Development of an Intravenous Bile Acid Tolerance Test. New Engl. J. Med., 292: 1205–1209, 1975.
37. Kreek, M. J. Cholestasis of Pregnancy and during Ethinyl Estradiol Administration in the Human and Rat. In: H. A. Salhanick, D. M. Kipnis, and R. L. Vande Welde (eds.) Conference on Metabolic Effects of Gonadal Hormones and Contraceptive Steroids, pp. 40–58. New York: Plenum Press, 1969.
38. LaRusso. N. F., Hoffman, N. E., Hoffman, A. F., and Korman, M. G. Validity and Sensitivity of an Intravenous Bile Acid Tolerance Test in Patients with Liver Disease. New Engl. J. Med., 292: 1209–1214, 1975.
39. Longmire, W. P., Jr., Trout, H. H., Greenfield, J., and Tompkins, R. K. Elective Hepatic Surgery. Ann. Surg., 179: 712–721, 1974.
40. Mays, E. T., Christopherson, W. M., and Barrows, G. H. Focal Nodular Hyperplasia of the Liver. Am. J. Clin. Pathol., 61: 735–746, 1974.
41. Meadows, A. T., Naiman, J. L., and Valdesdapena. M. Hepatoma Associated with Androgen Therapy for Aplastic Anemia. Pediatrics. 84. 109–110, 1974.
42. Meyer, P., Livolsi, V. A., and Cornog, J. L. Hepatoblastoma Associated with an Oral Contraceptive. Lancet, 2: 1387, 1974.
43. Mowat, A. P., and Arias, I. M. Liver Function and Oral Contraceptives. J. Reprod. Med., 3: 45–55, 1969.
44. Mueller, M. N., and Kappas, A. Estrogen Pharmacology. I. The Influence of Estradiol and Estriol on Hepatic Disposal of Sulfobromophthalein (BSP) in Man. J. Clin. Invest., 43: 1905–1914, 1964.
45. Perez, V., Gorosdisch, S., De Martire, J., Nicholson, R., and Di Paola, G. Oral Contraceptives: Long-term Use Produces Fine Structural Changes in Liver Mitochondria. Science, 165: 805–807, 1969.
46. Stauffer, J. Q., Lapinski, M. W., Honold, D. J., and Myers. J. K. Focal Nodular Hyperplasia of the Liver and Intrahepatic Hemorrhage in Young Women on Oral Contraceptives. Ann. Intern. Med., 83: 301–306, 1975.
47. Tephly, T. R., and Mannering, G. J. Inhibition of Drug Metabolism. V. Inhibition of Drug Metabolism by Steroids. Mol. Pharmacol. 4: 10–14, 1968.
48. Tountas, C., Paraskevas, G., and Deligeorgi, H. Benign Hepatoma and Oral Contraceptives. Lancet, 1: 1351–1352, 1974.
49. Warwick, G. P. Metabolism of Liver Carcinogens and Other Factors Influencing Liver Cancer Induction. In: Liver Cancer, Publ. 1, pp. 121–157. Lyon: International Agency For Research on Cancer, 1971.
50. Wheeler, H. O., Epstein, R. M., Robinson, R. R., and Snell, E. S. Hepatic Storage and Excretion of Sulfobromophthalein Sodium in Dogs. J. Clin. Invest., 39: 236–247, 1960.
51. Ziegenfuss, J., and Carabasi, R. Androgens and Hepatocellular Carcinoma. Lancet, 1: 262, 1973.